News

BioMed SA eyes new road map to greater economic wins

BioMed SA President Ann Stevens (Photo by Lyndsey Johnson) By W. Scott Bailey, San Antonio Business ...

Diabetes, Infectious Diseases Early Focus of San Antonio Biomed Plan

David Holley, Xconomy Texas —  San Antonio — [Updated 12/14/17, 11:54 p.m. See below.] ...

Industry Publications

The Mission

The Mission is published by the University of Texas Health Science Center.

UTSA Discovery

UTSA Discovery is published annually for the Office of the Vice President for Research by the Office ...

News
CEO David Spencer says Pryor Medical preparing to commercialize new trauma device
April 9, 2015

Pryor Medical Inc. CEO and co-founder David Spencer says the company expects to get an FDA clearance for its new device before the end of the year.

By W. Scott Bailey, San Antonio Business Journal

A local company co-founded by tech entrepreneur David Spencer is waiting for regulatory approval for a new medical device focused on traumatic injury.

San Antonio-based Pryor Medical Inc., with offices in Avada, Colo., could have that approval by the end of the year for the new device, intended to increase the percentage of military and civilian victims who survive traumatic injury.

Spencer, who also serves as CEO of Pryor, said the new device, the ER-REBOA (Resuscitative Endovascular Balloon Occlusion of the Aorta), is a special catheter designed to temporarily stop trauma-induced bleeding and protect vital organs through a less invasive technology.

A pair of individuals from the U.S. military and University of Michigan invented and secured a patent for the device. They have licensed the technology exclusively to Pryor Medical, which has improved the device and is now seeking to commercialize the product.

"We improve medicine based on lessons learned from war. Particularly if you look at trauma," Spencer said. "That's what Pryor Medical is all about - taking lessons learned from war that can also be applied to a large civilian market."

Spencer said one of the military's largest concerns is addressing potentially survivable wounds - especially from traumatic injuries involving truncal hemorrhaging.

"The Army has said enough. They want some solutions for truncal hemorrhage," Spencer said. "It's their number one cause of potentially survivable death.

"This is the same balloon technology used for heart stents and angioplasty," Spencer added about the new device. "Why not use it to stop bleeding? That's what our device does."

Once Pryor Medical obtains approval from the FDA for the ER-REBOA, it will begin to market the device for military and civilian use.

Salem, New Hampshire-based Vention Medical will manufacture the new device.

While Pryor will initially focus on the roll out of the ER-REBOA device, Spencer said the company it will look to expand its presence.

"Pryor is interested in anything that is related to military medical and has a large commercial market," he said.

 

Stay informed. Subscribe to BioMed SA news alerts.